Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of Upadacitinib (ABT-494) for Induction and Maintenance Therapy in Participants With Moderately to Severely Active Ulcerative Colitis (UC) [Phase 2, Phase 3]

View source ↗

Summary

A study evaluating safety and efficacy of upadacitinib for induction and maintenance therapy in moderately to severely active ulcerative colitis has completed P…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• Upadacitinib (upadacitinib)

Snippet

Sponsor: AbbVie | Conditions: Ulcerative Colitis (UC) | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2022-06-30